A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer - Concepedia

Concepedia

Publication | Closed Access

A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer

169

Citations

31

References

2019

Year

Cristina P. Rodriguez, Qian Wu, Jenna Voutsinas, Jonathan R. Fromm, Xiuyun Jiang, Venu G. Pillarisetty, Sylvia M. Lee, Rafael Santana-Dávila, Bernardo Goulart, Christina S. Baik,

Clinical Cancer Research

Abstract

This combination demonstrated activity in HN, with fewer responses in SGC. Toxicities were higher than reported with pembrolizumab alone.

References

	Year	Citations

Page 1